{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:26:35Z","timestamp":1794047195648,"version":"4.8.0"},"reference-count":209,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202306383"],"award-info":[{"award-number":["tsqn202306383"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqnz20221156"],"award-info":[{"award-number":["tsqnz20221156"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024MH097"],"award-info":[{"award-number":["ZR2024MH097"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021MH118"],"award-info":[{"award-number":["ZR2021MH118"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2025MS1272"],"award-info":[{"award-number":["ZR2025MS1272"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2024YFE0216000"],"award-info":[{"award-number":["2024YFE0216000"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jconrel.2025.114465","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T07:33:16Z","timestamp":1763969596000},"page":"114465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Long-acting lipid-based nanomedicines: rethinking from structure-based rational design to in vivo fate evaluation"],"prefix":"10.1016","volume":"389","author":[{"given":"Yixuan","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifu","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuansong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyou","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114465_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.jconrel.2025.114465_bb0010","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3390\/foods14060973","article-title":"Lipid nanoparticles: formulation, production methods and characterization protocols","volume":"14","author":"Ludtke","year":"2025","journal-title":"Foods"},{"key":"10.1016\/j.jconrel.2025.114465_bb0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114465_bb0020","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0025","article-title":"Effects of individual amino acids on the blood circulation of biosynthetic protein nanocages: toward guidance on surface engineering","volume":"12","author":"Liang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.114465_bb0030","doi-asserted-by":"crossref","first-page":"10795","DOI":"10.1021\/acs.analchem.3c01999","article-title":"PEG-lipids: quantitative study of unimers and aggregates thereof by the methods of molecular hydrodynamics","volume":"95","author":"Anufriev","year":"2023","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2025.114465_bb0035","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2025.114465_bb0040","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2025.114465_bb0045","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.apsb.2021.05.002","article-title":"A review of existing strategies for designing long-acting parenteral formulations: focus on underlying mechanisms, and future perspectives","volume":"11","author":"Shi","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.114465_bb0050","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2174\/1389200219666180511152350","article-title":"Advances in long-circulating drug delivery strategy","volume":"19","author":"Zhang","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jconrel.2025.114465_bb0055","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.3390\/pharmaceutics15112519","article-title":"Recent advances in long-acting drug delivery and formulations","volume":"15","author":"Al","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114465_bb0060","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","article-title":"Lipid-based nanoparticles for drug\/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development","volume":"3","author":"Mehta","year":"2023","journal-title":"ACS Materials Au"},{"key":"10.1016\/j.jconrel.2025.114465_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114465_bb0070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil(r)--the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0075","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/annonc\/mdh097","article-title":"Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX\/doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer","volume":"15","author":"O'Brien","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0080","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.bjc.6603345","article-title":"Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer","volume":"95","author":"White","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114465_bb0085","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","article-title":"Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies","volume":"42","author":"Gabizon","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2025.114465_bb0090","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1021\/js960037a","article-title":"Pharmacokinetics of cisplatin and its monohydrated complex in humans","volume":"85","author":"Andersson","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114465_bb0095","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2165\/00003495-199652040-00013","article-title":"Irinotecan. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer","volume":"52","author":"Wiseman","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2025.114465_bb0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12032-019-1309-6","article-title":"Comparison of conventional versus liposomal irinotecan in combination with fluorouracil for advanced pancreatic cancer: a single-institution experience","volume":"36","author":"Tossey","year":"2019","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0105","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/17425255.2019.1637417","article-title":"Pharmacokinetics and pharmacodynamics of new drugs for pancreatic cancer","volume":"15","author":"Sugarman","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0110","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41578-021-00405-w","article-title":"Clinical translation of long-acting drug delivery formulations","volume":"7","author":"Li","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.114465_bb0115","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1016\/j.apsb.2021.11.016","article-title":"The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers","volume":"12","author":"Fan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.114465_bb0120","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/17425247.2022.2093854","article-title":"Protein corona: challenges and opportunities for targeted delivery of nanomedicines","volume":"19","author":"Jiang","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.114465_bb0125","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1039\/D0BM01947J","article-title":"Illuminating endosomal escape of polymorphic lipid nanoparticles that boost mRNA delivery","volume":"9","author":"Herrera","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2025.114465_bb0130","doi-asserted-by":"crossref","unstructured":"Di J, X. Gao, Du Y, H. Zhang, J. Gao, A. Zheng, Size, shape, charge and \"stealthy\" surface: carrier properties affect the drug circulation time in vivo, Asian J. Pharm. Sci. 16 (2021) 444-458, doi: https:\/\/doi.org\/10.1016\/j.ajps.2020.07.005.","DOI":"10.1016\/j.ajps.2020.07.005"},{"key":"10.1016\/j.jconrel.2025.114465_bb0135","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1039\/D1TB01063H","article-title":"Interplay between nanomedicine and protein corona","volume":"9","author":"Yang","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2025.114465_bb0140","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1021\/ar2003336","article-title":"Metabolism of nanomaterials in vivo: blood circulation and organ clearance","volume":"46","author":"Wang","year":"2013","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2025.114465_bb0145","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/s41551-025-01404-w","article-title":"Rapid clearance of achiral small-molecule drugs using de novo-designed proteins and their cyclic and mirror-image variants","volume":"9","author":"Chen","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114465_bb0150","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp800049w","article-title":"Pharmacokinetics and biodistribution of nanoparticles","volume":"5","author":"Li","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.114465_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124799","article-title":"Effects of nanoparticle size, shape, and zeta potential on drug delivery","volume":"666","author":"Ozturk","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114465_bb0160","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12951-024-02812-x","article-title":"Role of size, surface charge, and PEGylated lipids of lipid nanoparticles (LNPs) on intramuscular delivery of mRNA","volume":"22","author":"Kong","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0165","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles horizontal line from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114465_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2020.101008","article-title":"Progress, challenges, and future of nanomedicine","volume":"35","author":"Zhang","year":"2020","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.114465_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106688","article-title":"Recent advances and clinical translation of liposomal delivery systems in cancer therapy","volume":"193","author":"Chen","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114465_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/750891","article-title":"Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery","volume":"2012","author":"Severino","year":"2012","journal-title":"J. Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.114465_bb0185","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jconrel.2012.09.006","article-title":"Liposomal paclitaxel formulations","volume":"163","author":"Koudelka","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104398","article-title":"Irinotecan: 25 years of cancer treatment","volume":"148","author":"Bailly","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2025.114465_bb0195","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1200\/JCO.2017.77.6112","article-title":"CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia","volume":"36","author":"Lancet","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003088-198815010-00002","article-title":"Clinical pharmacokinetics of doxorubicin","volume":"15","author":"Speth","year":"1988","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2025.114465_bb0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nano.2011.05.013","article-title":"A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems","volume":"8","author":"Kaminskas","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.114465_bb0210","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0215","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","article-title":"The current landscape of nucleic acid therapeutics","volume":"16","author":"Kulkarni","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"MRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114465_bb0225","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.114465_bb0230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41541-023-00766-z","article-title":"Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats","volume":"8","author":"Wang","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jconrel.2025.114465_bb0235","doi-asserted-by":"crossref","first-page":"101436","DOI":"10.1016\/j.omtm.2025.101436","article-title":"Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism","volume":"33","author":"Hosseini-Kharat","year":"2025","journal-title":"Mol.Ther.-Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2025.114465_bb0240","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1038\/s41467-018-05096-6","article-title":"Engineering circular RNA for potent and stable translation in eukaryotic cells","volume":"9","author":"Wesselhoeft","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114465_bb0245","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1021\/acsnano.2c02347","article-title":"Surface modification of lipid-based nanoparticles","volume":"16","author":"Xu","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114465_bb0250","doi-asserted-by":"crossref","first-page":"370","DOI":"10.34133\/research.0370","article-title":"Unlocking the therapeutic applicability of LNP-mRNA: chemistry, formulation, and clinical strategies","volume":"7","author":"Huang","year":"2024","journal-title":"Research"},{"key":"10.1016\/j.jconrel.2025.114465_bb0255","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1038\/s41467-024-50093-7","article-title":"Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation","volume":"15","author":"Su","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114465_bb0260","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11095-015-1784-1","article-title":"Polymeric micelles: recent advancements in the delivery of anticancer drugs","volume":"33","author":"Gothwal","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2025.114465_bb0265","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/jphp.12598","article-title":"Enhanced anticancer activity in vitro and in vivo of luteolin incorporated into long-circulating micelles based on DSPE-PEG2000 and TPGS","volume":"68","author":"Yan","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.3960","article-title":"Development and qualification of an LC-MS\/MS method for investigating the biological implications of micelle entrapped paclitaxel in cell culture and rats","volume":"31","author":"Kaddoumi","year":"2017","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jconrel.2025.114465_bb0275","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.4143\/crt.2022.1436","article-title":"Safety and tolerability of weekly genexol-PM, a cremophor-free polymeric micelle formulation of paclitaxel, with carboplatin in gynecologic cancer: a phase i study","volume":"55","author":"Nam","year":"2023","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.jconrel.2025.114465_bb0280","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10637-017-0506-4","article-title":"Phase i dose escalation and pharmacokinetic study on the nanoparticle formulation of polymeric micellar paclitaxel for injection in patients with advanced solid malignancies","volume":"36","author":"Shi","year":"2018","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.jconrel.2025.114465_bb0285","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1007\/s12274-018-2152-3","article-title":"Strategies to improve micelle stability for drug delivery","volume":"11","author":"Lu","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2025.114465_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102255","article-title":"Reexamining in vivo fate of paclitaxel-loaded polymeric micelles","volume":"56","author":"Lin","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.114465_bb0295","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1208\/s12249-025-03185-6","article-title":"Solid lipid nanoparticles: an innovative drug delivery system for enhanced bioavailability and targeted therapy","volume":"26","author":"Aggarwal","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2025.114465_bb0300","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15171\/apb.2015.043","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application","volume":"5","author":"Naseri","year":"2015","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2025.114465_bb0305","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114465_bb0310","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3109\/03639045.2014.956111","article-title":"Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance","volume":"41","author":"Ezzati","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2025.114465_bb0315","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/phrs.1999.0509","article-title":"Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN)","volume":"40","author":"Zara","year":"1999","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2025.114465_bb0320","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","article-title":"Solid lipid nanoparticles for parenteral drug delivery","volume":"56","author":"Wissing","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114465_bb0325","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.3390\/ijms24076199","article-title":"Solid lipid nanoparticles: applications and prospects in cancer treatment","volume":"24","author":"Sivadasan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.114465_bb0330","doi-asserted-by":"crossref","first-page":"495","DOI":"10.18433\/J3XK53","article-title":"Evaluation of solid lipid nanoparticles as carriers for delivery of hepatitis b surface antigen for vaccination using subcutaneous route","volume":"13","author":"Mishra","year":"2010","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114465_bb0335","doi-asserted-by":"crossref","first-page":"1444801","DOI":"10.3389\/fchem.2024.1444801","article-title":"The application of nanodiscs in membrane protein drug discovery & development and drug delivery","volume":"12","author":"Dong","year":"2024","journal-title":"Front. Chem."},{"key":"10.1016\/j.jconrel.2025.114465_bb0340","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/jsbi.1998.4007","article-title":"Reconstitution and imaging of a membrane protein in a nanometer-size phospholipid bilayer","volume":"123","author":"Bayburt","year":"1998","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0345","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62518","article-title":"Structure of bacterial phospholipid transporter MlaFEDB with substrate bound","volume":"9","author":"Coudray","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jconrel.2025.114465_bb0350","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1038\/s41467-022-32125-2","article-title":"Fusion protein strategies for cryo-EM study of g protein-coupled receptors","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114465_bb0355","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1039\/D1CS01074C","article-title":"Nanodiscs: a versatile nanocarrier platform for cancer diagnosis and treatment","volume":"51","author":"Bariwal","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.114465_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101609","article-title":"Morphology-driven protein corona manipulation for preferential delivery of lipid nanodiscs","volume":"46","author":"Chen","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.114465_bb0365","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1021\/acs.nanolett.2c01509","article-title":"Folic acid enables targeting delivery of lipodiscs by circumventing IgM-mediated opsonization","volume":"22","author":"Wang","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.114465_bb0370","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0375","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1021\/acsnano.8b01516","article-title":"On the formation and morphology of lipid nanoparticles containing ionizable cationic lipids and siRNA","volume":"12","author":"Kulkarni","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114465_bb0380","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2025.114465_bb0385","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/49.suppl_1.21","article-title":"AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience","volume":"49","author":"Adler-Moore","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2025.114465_bb0390","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal amphotericin b (AmBisome((r))): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2025.114465_bb0395","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1158\/0008-5472.CAN-05-4007","article-title":"Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy","volume":"66","author":"Drummond","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114465_bb0400","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114465_bb0405","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/annonc\/mdm374","article-title":"Multicenter phase II trial of genexol-PM, a novel cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer","volume":"18","author":"Kim","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0410","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114465_bb0415","doi-asserted-by":"crossref","first-page":"21206","DOI":"10.1021\/acsnano.4c18274","article-title":"Structure and morphology of lipid nanoparticles for nucleic acid drug delivery: a review","author":"Udepurkar","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114465_bb0420","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114465_bb0425","first-page":"3281","article-title":"Bridging membrane fluidity studies with a predictive model of drug encapsulation to address industrial challenges of liposomal injectables manufacturing, Drug Deliv","author":"Biscaia-Caleiras","year":"2025","journal-title":"Transl. Res."},{"key":"10.1016\/j.jconrel.2025.114465_bb0430","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1021\/acs.langmuir.0c00475","article-title":"Mechanical properties determination of DMPC, DPPC, DSPC, and HSPC solid-ordered bilayers","volume":"36","author":"Drabik","year":"2020","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2025.114465_bb0435","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/pharmaceutics14030543","article-title":"Methods of liposomes preparation: formation and control factors of versatile nanocarriers for biomedical and nanomedicine application","volume":"14","author":"Lombardo","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114465_bb0440","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1529\/biophysj.108.138123","article-title":"Interplay of unsaturated phospholipids and cholesterol in membranes: effect of the double-bond position","volume":"95","author":"Martinez-Seara","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2025.114465_bb0445","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1126\/science.1255288","article-title":"Lipid cell biology. Polyunsaturated phospholipids facilitate membrane deformation and fission by endocytic proteins","volume":"345","author":"Pinot","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114465_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2022.105180","article-title":"The in-vitro study of novel phospholipid micelles loaded with amphotericin b on plasmodium falciparum protozoan","volume":"245","author":"Rajablou","year":"2022","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.jconrel.2025.114465_bb0455","doi-asserted-by":"crossref","first-page":"21733","DOI":"10.1039\/C9NR09347H","article-title":"On the role of helper lipids in lipid nanoparticle formulations of siRNA","volume":"11","author":"Kulkarni","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2025.114465_bb0460","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","article-title":"Cationic liposome-mediated RNA transfection","volume":"86","author":"Malone","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114465_bb0465","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0005-2736(95)00268-5","article-title":"Fate of cationic liposomes and their complex with oligonucleotide in vivo","volume":"1281","author":"Litzinger","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2025.114465_bb0470","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1002\/anie.201203263","article-title":"Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo","volume":"51","author":"Jayaraman","year":"2012","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2025.114465_bb0475","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/acs.bioconjchem.8b00778","article-title":"Overcoming endosomal entrapment in drug delivery","volume":"30","author":"Pei","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2025.114465_bb0480","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11095-022-03460-2","article-title":"Structure and function of cationic and ionizable lipids for nucleic acid delivery","volume":"40","author":"Sun","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2025.114465_bb0485","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2010.01.035","article-title":"DC-chol\/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery","volume":"390","author":"Zhang","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114465_bb0490","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jconrel.2022.05.020","article-title":"Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to t cells","volume":"347","author":"Patel","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0495","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.xphs.2022.12.026","article-title":"Effect of cholesterol content of lipid composition in mRNA-LNPs on the protein expression in the injected site and liver after local administration in mice","volume":"112","author":"Kawaguchi","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114465_bb0500","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jconrel.2025.114465_bb0505","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00703-2","article-title":"Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits","volume":"253","author":"Awasthi","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114465_bb0510","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2022.09.002","article-title":"Stealth nanoparticles in oncology: facing the PEG dilemma","volume":"351","author":"Zalba","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0515","first-page":"E3351","article-title":"Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles","volume":"115","author":"Yanez","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.114465_bb0520","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10717544.2017.1388451","article-title":"Cleavable PEGylation: a strategy for overcoming the \"PEG dilemma\" in efficient drug delivery","volume":"24","author":"Fang","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.114465_bb0525","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.bbamem.2006.12.013","article-title":"Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding","volume":"1768","author":"Dos","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2025.114465_bb0530","doi-asserted-by":"crossref","first-page":"20304","DOI":"10.1021\/acsami.8b22693","article-title":"Role of liposome size, surface charge, and PEGylation on rheumatoid arthritis targeting therapy","volume":"11","author":"Ren","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.114465_bb0535","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.114465_bb0540","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0168-3659(03)00201-3","article-title":"Polymer vesicles in vivo: correlations with PEG molecular weight","volume":"90","author":"Photos","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0545","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1021\/mp200100f","article-title":"Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration","volume":"8","author":"Kuai","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.114465_bb0550","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jconrel.2014.07.062","article-title":"Nanoparticle multivalency counterbalances the ligand affinity loss upon PEGylation","volume":"194","author":"Hennig","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(01)00399-6","article-title":"Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes","volume":"1558","author":"Song","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2025.114465_bb0560","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jconrel.2023.06.027","article-title":"Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route","volume":"360","author":"Takata","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0565","doi-asserted-by":"crossref","first-page":"18769","DOI":"10.1021\/acsnano.4c06638","article-title":"Reciprocal interaction with neutrophils facilitates cutaneous accumulation of liposomes","volume":"18","author":"Ding","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114465_bb0570","doi-asserted-by":"crossref","first-page":"18419","DOI":"10.1021\/jacs.2c06877","article-title":"Engineering poly(ethylene glycol) nanoparticles for accelerated blood clearance inhibition and targeted drug delivery","volume":"144","author":"Tian","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.114465_bb0575","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s40883-021-00198-y","article-title":"Clinical relevance of pre-existing and treatment-induced anti-poly(ethylene glycol) antibodies","volume":"8","author":"Freire","year":"2022","journal-title":"Regen. Eng. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.114465_bb0580","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1021\/acsnano.9b03942","article-title":"Pseudo-anaphylaxis to polyethylene glycol (PEG)-coated liposomes: roles of anti-PEG IgM and complement activation in a porcine model of human infusion reactions","volume":"13","author":"Kozma","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114465_bb0585","first-page":"36","article-title":"Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors","volume":"74","author":"Richter","year":"1984","journal-title":"Int. Arch. Allergy Appl. Immunol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0590","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cncr.22739","article-title":"Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients","volume":"110","author":"Armstrong","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2025.114465_bb0595","doi-asserted-by":"crossref","first-page":"11804","DOI":"10.1021\/acs.analchem.6b03437","article-title":"Analysis of pre-existing IgG and IgM antibodies against polyethylene glycol (PEG) in the general population","volume":"88","author":"Yang","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2025.114465_bb0600","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1021\/acs.analchem.6b03109","article-title":"Measurement of pre-existing IgG and IgM antibodies against polyethylene glycol in healthy individuals","volume":"88","author":"Chen","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2025.114465_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.112669","article-title":"A generic method for the detection of polyethylene glycol specific IgG and IgM antibodies in human serum","volume":"474","author":"Ehlinger","year":"2019","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jconrel.2025.114465_bb0610","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2023.09.003","article-title":"Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipients","volume":"363","author":"Miao","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0615","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1016\/j.vaccine.2023.06.009","article-title":"Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing covid-19 vaccines: evidence for immunogenicity of PEG","volume":"41","author":"Kozma","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2025.114465_bb0620","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3324\/haematol.2020.258525","article-title":"Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated e. Coli asparaginase in children with acute lymphocytic leukemia","volume":"107","author":"Khalil","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.jconrel.2025.114465_bb0625","first-page":"2010","article-title":"Hydroxy polyethylene glycol: a solution to evade human pre-existing anti-PEG antibodies for efficient delivery","author":"Ding","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.jconrel.2025.114465_bb0630","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ejca.2008.01.028","article-title":"Pegylated liposomal doxorubicin-associated hand-foot syndrome: recommendations of an international panel of experts","volume":"44","author":"von Moos","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114465_bb0635","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1684\/ejd.2017.2986","article-title":"Immediate hypersensitivity reaction to pegylated liposomal doxorubicin: management and outcome in four patients","volume":"27","author":"Ingen-Housz-Oro","year":"2017","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.polymdegradstab.2020.109388","article-title":"Mass spectrometry investigation into the oxidative degradation of poly(ethylene glycol)","volume":"183","author":"Payne","year":"2021","journal-title":"Polym. Degrad. Stab."},{"key":"10.1016\/j.jconrel.2025.114465_bb0645","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154-155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114465_bb0650","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1021\/acs.molpharmaceut.9b00770","article-title":"Accelerated blood clearance of nanoemulsions modified with PEG-cholesterol and PEG-phospholipid derivatives in rats: the effect of PEG-lipid linkages and PEG molecular weights","volume":"17","author":"Liu","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.114465_bb0655","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ymthe.2005.09.014","article-title":"Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes","volume":"13","author":"Judge","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.114465_bb0660","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1016\/j.biomaterials.2010.02.049","article-title":"Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes","volume":"31","author":"Xu","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114465_bb0665","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41392-024-01871-8","article-title":"Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis b virus infection","volume":"9","author":"Zai","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114465_bb0670","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jconrel.2020.12.047","article-title":"Anti-PEG scfv corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicines","volume":"330","author":"Zhang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0675","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/S0142-9612(01)00050-3","article-title":"Amphiphilic poly-n-vinylpyrrolidones: synthesis, properties and liposome surface modification","volume":"22","author":"Torchilin","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114465_bb0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.06.023","article-title":"The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes","volume":"213","author":"Kierstead","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2014.11.010","article-title":"Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior","volume":"41","author":"Li","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114465_bb0690","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1021\/acs.langmuir.9b00610","article-title":"Poly-phosphocholinated liposomes form stable superlubrication vectors","volume":"35","author":"Lin","year":"2019","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2025.114465_bb0695","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.7150\/thno.111685","article-title":"Zwitterionic lipid nanoparticles for efficient siRNA delivery and hypercholesterolemia therapy with rational charge self-transformation","volume":"15","author":"Zhao","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.114465_bb0700","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/614619","article-title":"CD47: a cell surface glycoprotein which regulates multiple functions of hematopoietic cells in health and disease","volume":"2013","author":"Oldenborg","year":"2013","journal-title":"ISRN Hematol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0705","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004589","article-title":"CD47\/SIRPalpha axis: bridging innate and adaptive immunity","volume":"10","author":"van Duijn","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2025.114465_bb0710","doi-asserted-by":"crossref","first-page":"13015","DOI":"10.1021\/acsnano.9b05679","article-title":"Overcoming the reticuloendothelial system barrier to drug delivery with a \"don't-eat-us\" strategy","volume":"13","author":"Tang","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114465_bb0715","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1229568","article-title":"Minimal \"self\" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles","volume":"339","author":"Rodriguez","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114465_bb0720","doi-asserted-by":"crossref","first-page":"18100","DOI":"10.1021\/acsnano.1c06707","article-title":"Precise delivery of nanomedicines to m2 macrophages by combining \u201ceat me\/don\u2019t eat me\u201d signals and its anticancer application","volume":"15","author":"Tang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114465_bb0725","doi-asserted-by":"crossref","first-page":"26269","DOI":"10.1038\/srep26269","article-title":"Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes","volume":"6","author":"Qie","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114465_bb0730","article-title":"Biomimetic nano-degrader based CD47-SIRPalpha immune checkpoint inhibition promotes macrophage efferocytosis for cardiac repair","volume":"11","author":"Gao","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.114465_bb0735","doi-asserted-by":"crossref","first-page":"33875","DOI":"10.1021\/acsnano.4c07074","article-title":"Biomimetic nanovesicles synergize with short-term fasting for enhanced chemotherapy of triple-negative breast cancer","volume":"18","author":"Chiang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114465_bb0740","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jconrel.2025.02.012","article-title":"A rapamycin-loading platelet membrane hybrid liposome with anti-inflammation effect and long-lasting repair capability for acute kidney injury","volume":"380","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0745","doi-asserted-by":"crossref","first-page":"39064","DOI":"10.1021\/acsami.3c05861","article-title":"Apoptotic neutrophil membrane-camouflaged liposomes for dually targeting synovial macrophages and fibroblasts to attenuate osteoarthritis","volume":"15","author":"Deng","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.114465_bb0750","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1021\/jacs.9b09617","article-title":"Corona exchange dynamics on carbon nanotubes by multiplexed fluorescence monitoring","volume":"142","author":"Pinals","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.114465_bb0755","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41565-018-0344-3","article-title":"Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles","volume":"14","author":"Vu","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0760","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nnano.2015.330","article-title":"Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers","volume":"11","author":"Schottler","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0765","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.4049\/jimmunol.1301673","article-title":"Complement activation by ceramide transporter proteins","volume":"192","author":"Bode","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0770","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jconrel.2021.04.025","article-title":"Interrogating preclinical study of liposomes: the effect of mouse strain reexamined","volume":"334","author":"Guan","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0775","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1016\/j.apsb.2024.07.009","article-title":"Exemplifying interspecies variation of liposome in vivo fate by the effects of anti-PEG antibodies","volume":"14","author":"Wu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2025.114465_bb0780","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1038\/s41467-018-05384-1","article-title":"Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption","volume":"9","author":"Guan","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114465_bb0785","doi-asserted-by":"crossref","first-page":"14779","DOI":"10.1021\/acsnano.0c02821","article-title":"Interrogation of folic acid-functionalized nanomedicines: the regulatory roles of plasma proteins reexamined","volume":"14","author":"Wang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114465_bb0790","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jconrel.2022.02.030","article-title":"CRGD enables rapid phagocytosis of liposomal vancomycin for intracellular bacterial clearance","volume":"344","author":"Li","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0795","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jconrel.2021.08.048","article-title":"Complement opsonization of nanoparticles: differences between humans and preclinical species","volume":"338","author":"Li","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0800","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): the nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0805","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1067\/mai.2002.120954","article-title":"A role for c5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria","volume":"109","author":"Kikuchi","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0810","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41565-023-01444-w","article-title":"Transport by circulating myeloid cells drives liposomal accumulation in inflamed synovium","volume":"18","author":"Deprez","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0815","doi-asserted-by":"crossref","first-page":"11584","DOI":"10.1021\/acsnano.7b06524","article-title":"Revealing dynamics of accumulation of systemically injected liposomes in the skin by intravital microscopy","volume":"11","author":"Griffin","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114465_bb0820","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0825","article-title":"Understanding nanomaterial-liver interactions to facilitate the development of safer nanoapplications","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114465_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114238","article-title":"Why nanoparticles prefer liver macrophage cell uptake in vivo","volume":"185","author":"Ngo","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114465_bb0835","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/nmat4718","article-title":"Mechanism of hard-nanomaterial clearance by the liver","volume":"15","author":"Tsoi","year":"2016","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2025.114465_bb0840","doi-asserted-by":"crossref","DOI":"10.1038\/s41565-025-01903-6","article-title":"Discovering nanoparticle corona ligands for liver macrophage capture","author":"Bussin","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0845","article-title":"Reticuloendothelial system blockade does not enhance siRNA-LNP circulation or tumor accumulation in mice","volume":"9","author":"Escude","year":"2025","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.jconrel.2025.114465_bb0850","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1021\/acsnano.2c00423","article-title":"PEGylated liposomes accumulate in the areas relevant to skin toxicities via passive extravasation across \"leaky\" endothelium","volume":"16","author":"Li","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114465_bb0855","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","article-title":"Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?","volume":"27","author":"Nakamura","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2025.114465_bb0860","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.copbio.2020.07.006","article-title":"Engineering long-circulating nanomaterial delivery systems","volume":"66","author":"Fan","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0865","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1049\/nbt2.12028","article-title":"Liposome nano-formulation with cationic polar lipid DOTAP and cholesterol as a suitable ph-responsive carrier for molecular therapeutic drug (all-trans retinoic acid) delivery to lung cancer cells","volume":"15","author":"Grace","year":"2021","journal-title":"IET Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0870","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1020134521778","article-title":"Liposome clearance","volume":"22","author":"Ishida","year":"2002","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.jconrel.2025.114465_bb0875","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1038\/s41467-024-50568-7","article-title":"Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin","volume":"15","author":"Jiang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114465_bb0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120574","article-title":"Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate","volume":"300","author":"Sheikholeslami","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2025.114465_bb0885","doi-asserted-by":"crossref","first-page":"10764","DOI":"10.1021\/acs.langmuir.5b02158","article-title":"Stealth effect of biomolecular corona on nanoparticle uptake by immune cells","volume":"31","author":"Caracciolo","year":"2015","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2025.114465_bb0890","first-page":"1342","article-title":"PBPK model of pegylated liposomal doxorubicin to simultaneously predict the concentration-time profile of encapsulated and free doxorubicin in tissues, Drug Deliv","volume":"15","author":"Cao","year":"2025","journal-title":"Transl. Res."},{"key":"10.1016\/j.jconrel.2025.114465_bb0895","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.tcb.2011.09.005","article-title":"From 3d cell culture to organs-on-chips","volume":"21","author":"Huh","year":"2011","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0900","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2011.09.063","article-title":"Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress","volume":"161","author":"Lammers","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0905","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.004","article-title":"Endosomal escape pathways for delivery of biologicals","volume":"151","author":"Varkouhi","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0910","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41551-016-0010","article-title":"Near-infrared fluorophores for biomedical imaging","volume":"1","author":"Hong","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114465_bb0915","doi-asserted-by":"crossref","first-page":"30907","DOI":"10.1021\/jacs.5c07897","article-title":"MRNA-based FRET-FLIM imaging platform for quantifying lipid nanoparticle endosomal escape and membrane damage","volume":"147","author":"Fang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.114465_bb0920","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nmat2442","article-title":"Understanding biophysicochemical interactions at the nano-bio interface","volume":"8","author":"Nel","year":"2009","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2025.114465_bb0925","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fchem.2018.00360","article-title":"Nanomedicine: principles, properties, and regulatory issues","volume":"6","author":"Soares","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.jconrel.2025.114465_bb0930","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114465_bb0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125202","article-title":"Navigating translational research in nanomedicine: a strategic guide to formulation and manufacturing","volume":"671","author":"Zhang","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114465_bb0940","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.114465_bb0945","article-title":"Size-dependent penetration of nanoparticles in tumor spheroids: a multidimensional and quantitative study of transcellular and paracellular pathways","volume":"20","author":"Chen","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.114465_bb0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124540","article-title":"Optimization of polyethylene glycol shielding and mannose density on the lipid nanoparticles for efficient delivery to macrophages and spleens","volume":"662","author":"Yeo","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114465_bb0955","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jconrel.2019.05.030","article-title":"Liposome and immune system interplay: challenges and potentials","volume":"305","author":"Zahednezhad","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114465_bb0960","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/08982100902792855","article-title":"Liposome triggering of innate immune responses: a perspective on benefits and adverse reactions","volume":"19","author":"Szebeni","year":"2009","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2025.114465_bb0965","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3390\/vaccines12101148","article-title":"Recent advances in lipid nanoparticles and their safety concerns for mRNA delivery","volume":"12","author":"Wang","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2025.114465_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.172240","article-title":"Impact of physicochemical properties on biological effects of lipid nanoparticles: are they completely safe","volume":"927","author":"Yuan","year":"2024","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.jconrel.2025.114465_bb0975","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","article-title":"Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release","volume":"116","author":"Kamaly","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.114465_bb0980","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"Bangham","year":"1965","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0985","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrd4539","article-title":"Organs-on-chips at the frontiers of drug discovery","volume":"14","author":"Esch","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.114465_bb0990","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s00204-017-2002-1","article-title":"Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury","volume":"91","author":"Proctor","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jconrel.2025.114465_bb0995","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41576-022-00466-9","article-title":"Human organs-on-chips for disease modelling, drug development and personalized medicine","volume":"23","author":"Ingber","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2025.114465_bb1000","doi-asserted-by":"crossref","first-page":"32640","DOI":"10.1021\/acsami.1c00794","article-title":"On-chip construction of liver lobules with self-assembled perfusable hepatic sinusoid networks","volume":"13","author":"Ya","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.114465_bb1005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-022-01278-4","article-title":"Tumor organoids: applications in cancer modeling and potentials in precision medicine","volume":"15","author":"Xu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2025.114465_bb1010","doi-asserted-by":"crossref","first-page":"17404","DOI":"10.1039\/D4NR02793K","article-title":"Liposome biodistribution mapping with in vivo x-ray fluorescence imaging","volume":"16","author":"Saladino","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2025.114465_bb1015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.addr.2020.07.017","article-title":"Nuclear imaging approaches facilitating nanomedicine translation","volume":"154-155","author":"Perez-Medina","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114465_bb1020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.addr.2018.12.007","article-title":"Superparamagnetic iron oxides as MPI tracers: a primer and review of early applications","volume":"138","author":"Bulte","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.114465_bb1025","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12052","article-title":"Measuring particle concentration of multimodal synthetic reference materials and extracellular vesicles with orthogonal techniques: who is up to the challenge?","volume":"10","author":"Vogel","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.jconrel.2025.114465_bb1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118340","article-title":"Machine learning-driven nanoparticle toxicity","volume":"299","author":"Hosni","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.jconrel.2025.114465_bb1035","doi-asserted-by":"crossref","first-page":"10804","DOI":"10.1038\/s41467-024-55072-6","article-title":"Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114465_bb1040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cmpb.2016.04.025","article-title":"A review of the applications of data mining and machine learning for the prediction of biomedical properties of nanoparticles","volume":"132","author":"Jones","year":"2016","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.jconrel.2025.114465_bb1045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.yrtph.2011.02.002","article-title":"Predictive models for nanotoxicology: current challenges and future opportunities","volume":"59","author":"Clark","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592501079X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592501079X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:45:05Z","timestamp":1794044705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592501079X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":209,"alternative-id":["S016836592501079X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114465","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-acting lipid-based nanomedicines: rethinking from structure-based rational design to in vivo fate evaluation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114465"}}